Old Web
English
Sign In
Acemap
>
Paper
>
PL03.03: Randomized Phase III Study of Osimertinib vs Platinum-Pemetrexed for EGFR T790M-Positive Advanced NSCLC (AURA3)
PL03.03: Randomized Phase III Study of Osimertinib vs Platinum-Pemetrexed for EGFR T790M-Positive Advanced NSCLC (AURA3)
2017
Vassiliki Papadimitrakopoulou
Yi-Long Wu
Myung-Ju Ahn
Suresh S. Ramalingam
Marina Chiara Garassino
Hye Ryun Kim
Frances A. Shepherd
Hiroaki Akamatsu
Willemijn Theelen
Chee Khoon Lee
Martin Sebastian
A. Templeton
Marcelo Marotti
Serban Ghiorghiu
Tony Mok
Keywords:
Pemetrexed
Pathology
EGFR T790M
Osimertinib
Oncology
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]